Local treatment of tendinopathies: A comparison between tropisetron and depot corticosteroids combined with local anesthetics

Scandinavian Journal of Rheumatology

Volumn 31, Issue 6, 2002, Pages 366-370

  Stratz, Th ^a   Farber L ^b   Müller, Wolfgang ^c  

^a H Inst fur Rehabilitationsfr e V   (Germany)

^b UNIVERSITY OF REGENSBURG   (Germany)

^c Department Klinische Forschung ^*  (Germany)

Author keywords

5 HT3 receptor antagonists; Corticosteroids; Local anesthetic; Tendinopathy; Therapy

Indexed keywords

CORTICOSTEROID; DEXAMETHASONE; DEXAMETHASONE ACETATE; LIDOCAINE; LOCAL ANESTHETIC AGENT; NAVONBAN; SEROTONIN 3 ANTAGONIST; TROPISETRON;

ADULT; AGED; ARTICLE; BODY MOVEMENT; CLINICAL ARTICLE; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG BINDING; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; HUMAN; LOCAL ANESTHESIA; MALE; PAIN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STEROID THERAPY; TENDON DISEASE;

EID: 0036438104     PISSN: 03009742     EISSN: None     Source Type: Journal    
DOI: 10.1080/030097402320817103     Document Type: Article

References (27)

1. Almekinders LC. Tendinitis and other chronic tendinopathies. J Am Acad Orthop Surg 1998;6:157-64.
2. Sheon RP, Moskowitz RW, Goldberg VM. Soft Tissue Rheumatic Pain. 3. Ed., Baltimore, MD, USA, Williams and Wilkins 1996.
3. Weiser HJ. Semimembranous insertion syndrome: A treatable and frequent cause of medial knee pain. Arch Phys Med Rehabil 1979;60:317-9.
4. Adebajo AO, Nash P, Hazleman BL. A prospective double blind dummy placebo controlled study comparing trianicinolone hexacetonide injection with oral diclofenac 50mg TDS in patients with rotator cuff tendinitis. J Rheumatol 1990;17:1207-10.
5. Assendelft WJ, Hay EM, Adshead R, Bouter LM. Corticosteroid injection for lateral epicondylitis: A systemic overview. Br J Gen Pract 1996;46:209-16.
6. Hollingworth GR, Ellis RM, Hattersley TM. Comparison of injection technique for shoulder pain: Results of a double blind randomized study. Brit Med J 1983;287:1339-41.
7. Dacre JE, Beeney N, Scott DL. Injection and physiotherapy for the painful stiff shoulder. Ann Rheum Dis 1989;48:322-5.
8. Stahl S, Kaufman T. The efficacy of an injection of steroids for medial epicondylitis. A prospective study of sixty elbows. J Bone Joint Surg Am 1997;79:1648-52.
9. Smidt N, Assendelft WJ, van der Windt DA, Hay EM, Buchbinder R, Bouter LM. Corticosteroid injection for lateral epicondylitis: A systematic review. Pain 2002;96:23-40.
10. Axchrod L. Steroids. In: WN Kelly, ED Harris jr. S. Ruddy, CD Sledge eds. Textbook of Rheumatology. Philadelphia, London, Torronto; Saunders Comp 1981:822-35.
11. Müller W, Stratz T, Schochat T, Mennet P. Die therapie der fibromyalgie mit 5-HT3-rezeptor-antagonisten. Z Rheumatol 1994;53 Suppl 1:24.
12. Stratz T, Schochat T, Hrycaj P, Lacki J, Färber L, Schweiger CH, et al. Die therapie der generalisierten tendomyopathie (Fibromyalgie) dutch blockierung der 5-HT3-rezeptoren. Z Rheumatol 1994;53:335-8.
13. Färber L, Stratz T, Müller W. New aspects for the medical treatment of fibromyalgia. Results of a double blind, randomized, placebo-controlled multi-centre trial evaluating the efficacy and tolerability of the 5-HT3-antagonist tropisetron in primary fibromyalgia. Z Rheumatol 1998;57 Suppl. 1:30.
14. Färber L, Stratz T, Brückle W, et al. Efficacy and tolerability of tropisetron in primary fibromyalgia - A highly selective and competitive 5-HT3-receptor antagonist. Scand J Rheumatol 2000;29 Suppl 113:49-54.
15. Stratz T, Müller W. The use of 5-HT3-receptor-antagonists in various rheumatic diseases - A clue to the mechanism of action of these agents in fibromyalgia. Scand J Rheumatol 2000;29 Suppl. 113:66-71.
16. Stratz T, Varga B, Müller W. Treatment of tendinopathies with tropisetron. Rheumatol Int (in press).
17. Caileiet R, ed. Soft Tissue Pain and Disability. Ed. 3, Philadelphia, Davis Comp 1996.
18. Kokemohr H. Praxis der Therapeutischen Lokalanästhesie und Neuraltherapie. Berlin, Heidelberg, New York, Springer 2000.
19. Gordon JL. Platelets and inflammation. In: WN Kelly, ED Harris jr, S. Ruddy, CD Sledge eds. Textbook of Rheumatology. Philadelphia, London, Toronto; Saunders Comp 1981:163-78.
20. Richardson BP, Engel G, Donatsch P, Stadler PA. Identification of serotonin M-receptor subtypes and their specific blockade by a new class of drugs. Nature 1985;316:126-31.
21. Giordano J, Rogers LV. Peripherally administered serotonin 5-HT3-receptor antagonists reduce inflammatory pain in rats. Eur J Pharmacol 1989;170:83-6.
22. Giordano J, Daleo C, Sacks SM. Topical ondansetron attenuates nociceptive and inflammatory effects of intradermal capsaicin in humans. Eur J Pharmacol 1998;354:13-4.
23. Greenshaw AJ, Silverstone PH. The non-anti-emetic uses of serotonin 5-HT3-receptor-antagonists. Drug 1997;55:20-30.
24. Ambesh SP, Dubey PK, Sinha PK. Ondansetron pretreatment to alleviate pain on propofol injection: A randomized, controlled, double-blind study. Anesth Analg 1999;89:197-9.
25. Ali Z, Wu G, Kozlov A, Barasi S. The role of 5-HT3 in nociceptive processing in the rat spinal cord: Results from behavioural and electrophysiological studies. Neurosci Lett 1996;208:203-7.
26. Glaum SR, Proudfit HK, Anderson EG. Reversal of the antinociceptive effects of intrathecally administered serotonin in the rat by a selective antagonist. Neurosci Lett 1988;95:313-7.
27. Saria A, Javorsky F, Humpel C, Gamse R. 5-HT3-receptor antagonists inhibit sensory neuropeptide release from the rat spinal cord. Neuroreport 1990;1:104-6.